Investigators remain committed to our current clinical trials during the COVID19 restrictions on in person contact.

  • De Souza continues to advocate for return of visits that can be executed safely with proper personal protective equipment (PPE) in place so that interim and final measurements can be made in the study on bone health in postmenopausal women.
  • Hooshmand and Kern report that they plan to be back in the lab in the middle of June and do not anticipate any delays in their study on bone health in women on oral contraceptive agents.
  • Arjmandi is awaiting IRB approval to begin in person visits in his research on prunes and rate of fracture healing.
  • Kim/Clifton report that the IRB has approved their study in South Korea and arrangements are being made for prune shipments.